Ethic Inc’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$460K Buy
2,103
+137
+7% +$30K 0.01% 840
2025
Q1
$433K Sell
1,966
-1,382
-41% -$304K 0.01% 839
2024
Q4
$1.1M Sell
3,348
-3,751
-53% -$1.23M 0.02% 571
2024
Q3
$2.81M Sell
7,099
-635
-8% -$251K 0.07% 313
2024
Q2
$2.55M Buy
7,734
+635
+9% +$209K 0.06% 321
2024
Q1
$2.81M Sell
7,099
-408
-5% -$161K 0.07% 313
2023
Q4
$2.64M Sell
7,507
-929
-11% -$327K 0.08% 304
2023
Q3
$3.17M Sell
8,436
-1,115
-12% -$418K 0.11% 221
2023
Q2
$3.65M Buy
9,551
+342
+4% +$131K 0.14% 185
2023
Q1
$3.19M Buy
9,209
+2,663
+41% +$923K 0.13% 204
2022
Q4
$1.54M Buy
6,546
+431
+7% +$101K 0.08% 289
2022
Q3
$1.51M Sell
6,115
-177
-3% -$43.6K 0.1% 251
2022
Q2
$1.9M Sell
6,292
-30
-0.5% -$9.07K 0.13% 202
2022
Q1
$2.6M Buy
6,322
+1,582
+33% +$650K 0.18% 142
2021
Q4
$2.22M Buy
4,740
+1,087
+30% +$510K 0.17% 146
2021
Q3
$1.55M Sell
3,653
-125
-3% -$53.1K 0.16% 166
2021
Q2
$1.36M Buy
3,778
+638
+20% +$229K 0.16% 153
2021
Q1
$885K Buy
3,140
+742
+31% +$209K 0.16% 173
2020
Q4
$679K Buy
2,398
+588
+32% +$166K 0.18% 142
2020
Q3
$498K Buy
+1,810
New +$498K 0.19% 134